| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| thiopental | muscarinic acetylcholine receptor m3 | small molecule | NA | drugbank | Intracranial Hypertension[MeSHID:D019586] Muscle relaxation phase[MeSHID:D009126] Abnormal behavior[MeSHID:D000066553] Convulsions[MeSHID:D012640] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,vet_approved | unknown |
| thiopental | neuronal acetylcholine receptor subunit alpha-4 | small molecule | NA | drugbank , DGIDB | Intracranial Hypertension[MeSHID:D019586] Muscle relaxation phase[MeSHID:D009126] Abnormal behavior[MeSHID:D000066553] Convulsions[MeSHID:D012640] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.71 | approved,vet_approved | antagonist |
| thiopental | neuronal acetylcholine receptor subunit alpha-7 | small molecule | NA | drugbank , DGIDB | Intracranial Hypertension[MeSHID:D019586] Muscle relaxation phase[MeSHID:D009126] Abnormal behavior[MeSHID:D000066553] Convulsions[MeSHID:D012640] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.66 | approved,vet_approved | antagonist |
| thiopental | fatty-acid amide hydrolase 1 | small molecule | NA | drugbank , DGIDB | Intracranial Hypertension[MeSHID:D019586] Muscle relaxation phase[MeSHID:D009126] Abnormal behavior[MeSHID:D000066553] Convulsions[MeSHID:D012640] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.83 | approved,vet_approved | inhibitor |
| thiopental | gamma-aminobutyric acid receptor subunit alpha-1 | small molecule | NA | drugbank , DGIDB | Intracranial Hypertension[MeSHID:D019586] Muscle relaxation phase[MeSHID:D009126] Abnormal behavior[MeSHID:D000066553] Convulsions[MeSHID:D012640] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.42 | approved,vet_approved | potentiator |
| thiopental | gamma-aminobutyric acid receptor subunit alpha-2 | small molecule | NA | drugbank , DGIDB | Intracranial Hypertension[MeSHID:D019586] Muscle relaxation phase[MeSHID:D009126] Abnormal behavior[MeSHID:D000066553] Convulsions[MeSHID:D012640] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.28 | approved,vet_approved | potentiator |
| thiopental | gamma-aminobutyric acid receptor subunit alpha-3 | small molecule | NA | drugbank , DGIDB | Intracranial Hypertension[MeSHID:D019586] Muscle relaxation phase[MeSHID:D009126] Abnormal behavior[MeSHID:D000066553] Convulsions[MeSHID:D012640] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.28 | approved,vet_approved | potentiator |
| thiopental | gamma-aminobutyric acid receptor subunit alpha-4 | small molecule | NA | drugbank , DGIDB | Intracranial Hypertension[MeSHID:D019586] Muscle relaxation phase[MeSHID:D009126] Abnormal behavior[MeSHID:D000066553] Convulsions[MeSHID:D012640] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.24 | approved,vet_approved | potentiator |
| thiopental | gamma-aminobutyric acid receptor subunit alpha-5 | small molecule | NA | drugbank , DGIDB | Intracranial Hypertension[MeSHID:D019586] Muscle relaxation phase[MeSHID:D009126] Abnormal behavior[MeSHID:D000066553] Convulsions[MeSHID:D012640] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.29 | approved,vet_approved | potentiator |
| thiopental | gamma-aminobutyric acid receptor subunit alpha-6 | small molecule | NA | drugbank , DGIDB | Intracranial Hypertension[MeSHID:D019586] Muscle relaxation phase[MeSHID:D009126] Abnormal behavior[MeSHID:D000066553] Convulsions[MeSHID:D012640] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.31 | approved,vet_approved | potentiator |
| thiopental | glutamate receptor 2 | small molecule | NA | drugbank , DGIDB | Intracranial Hypertension[MeSHID:D019586] Muscle relaxation phase[MeSHID:D009126] Abnormal behavior[MeSHID:D000066553] Convulsions[MeSHID:D012640] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.7 | approved,vet_approved | antagonist |
| thiopental | glutamate receptor ionotropic, kainate 2 | small molecule | NA | drugbank , DGIDB | Intracranial Hypertension[MeSHID:D019586] Muscle relaxation phase[MeSHID:D009126] Abnormal behavior[MeSHID:D000066553] Convulsions[MeSHID:D012640] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
1.54 | approved,vet_approved | antagonist |
| click here to return to the previous page | ||||||||